Treating Blood Cancers

Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH Recorded on May 13, 2025 Aaron Gerds, MD, MS Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University School of Medicine Medical Director Case Comprehensive Cancer Center Clinical Research Office Cleveland, OH In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs! This episode is supported by GSK plc and Karyopharm Therapeutics.

Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY Recorded on April 24, 2025 Tessa Faye Flores, MD Medical Director, Cancer Screening and Survivorship Roswell Park Comprehensive Cancer Center Buffalo, NY We are pleased to celebrate the 100th episode of Treating Blood Cancers with Dr. Tessa Flores from Roswell Park Comprehensive Cancer Center in Buffalo, New York, as she shares insights into survivorship care. In this episode, Dr. Flores explores the different phases of survivorship and the psychosocial challenges that accompany each stage. She highlights the vital role of a collaborative care team, including primary care practitioners, in supporting survivors of cancer to achieve and maintain a healthy post-treatment life. As the number of survivors continues to grow, the focus on long-term wellness becomes increasingly important. Dr. Flores emphasizes, “A tenet of survivorship care is preventive care”. Tune in for this special episode and join the conversation today! This episode is supported by Genentech, A Member of the Roche Group. Additional Episodes on Survivorship Care:

Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL Recorded on April 17, 2025 Mikkael A. Sekeres, MD, MS Chief, Division of Hematology Professor of Medicine Sylvester Comprehensive Cancer Center University of Miami Miami, FL Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and clinical trials. Dr. Sekeres also shares strategies for managing side effects and emphasizes the importance of multidisciplinary care in improving patient outcomes. Tune in to gain valuable insights on MDS today!

Jeffrey Magee, MD, PhD, Washington University School of Medicine, St. Louis, MO Recorded on April 3, 2025 Jeffrey Magee, MD, PhD Elizabeth H. and James S. McDonnell III Professor of Pediatrics Director, McDonnell Pediatric Cancer Center Division of Pediatric Hematology and Oncology Washington University School of Medicine St. Louis, MO In this episode, we sit down with Dr. Jeffrey Magee from the McDonald Pediatric Cancer Center at the Washington University School of Medicine in St. Louis to discuss the evolving landscape of pediatric blood cancers. Reflecting on his work, Dr. Magee shares, “One of the things I really love about the job is that it operates right at the interface between the science and the professional practice of medicine.” He examines groundbreaking advances bringing new hope to children and their families, from novel therapies and CAR T-cell therapy to the crucial role of clinical trials. Dr. Magee also speaks candidly about the challenges of delivering difficult news and shares compassionate strategies for supporting families through their toughest moments. Join us for this insightful and informative conversation on the future of pediatric blood cancer care today!

Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN Recorded on March 18, 2025 Angela Dispenzieri, MD Consultant, Division of Hematology Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine and Pathology Mayo Clinic Rochester, MN Join us as we dive into in the complex care of amyloid and myeloma with Dr. Angela Dispenzieri from Mayo Clinic Rochester, Minnesota. She explains the diagnosis and explores the differences between amyloid and myeloma. Discussion on treatment strategies for complex cases, side effects of therapies, and difficult conversations with patients, provide practical information on patient care. Tune in today to learn more about the complexities of myeloma. This episode is supported by GSK plc.

Guy Maytal, MD, Forge Health and Weill Cornell Medicine, New York, NY Recorded on February 20, 2025 Guy Maytal, MD Chief Medical Officer, Forge Health White Plains, NY Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine New York, NY In this episode, Dr. Guy Maytal, from Forge Health and Weill Cornell Medicine in New York, explores burnout and wellness in healthcare professionals, highlighting the difference between burnout and compassion fatigue. He shares valuable insights on recognizing these issues, while emphasizing the importance of connection, resilience, and self-care in preventing and overcoming burnout. Dr. Maytal also offers practical strategies for institutions to better support healthcare professionals. Tune in for the latest insights on healthcare professional wellness today!

Timothy Pearman, PhD, ABPP, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on February 6, 2025 Timothy Pearman, PhD, ABPP Director, Supportive Oncology Robert H. Lurie Comprehensive Cancer Center Professor, Department of Medical Social Sciences and Psychiatry & Behavioral Sciences Northwestern University Feinberg School of Medicine Chicago, IL Join us for an insightful episode featuring Dr. Timothy Pearman from Northwestern University, as he explores the critical role of caregivers and care partners to a patient's healthcare team. Dr. Pearman discusses the challenges caregivers face, including burnout, relationship stress, and issues surrounding sex and intimacy. He also offers effective communication strategies to address these challenges and shares ways healthcare professionals can better educate and support caregivers. Tune in to this informative podcast for valuable insights and resources for caregivers! This episode is supported by Genentech, A Member of the Roche Group.

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX Recorded on January 21, 2025 Jason Westin, M.D., MS, FACP Professor, Department of Lymphoma & Myeloma Lead, Lymphoma & Myeloma Service Line Director, Lymphoma Clinical Research Section Chief, Aggressive and Indolent Lymphoma MD Anderson Cancer Center Houston, TX In this episode, Dr. Jason Westin from MD Anderson Cancer Center in Houston, Texas explores CAR T-cell therapy, covering both current and emerging indications. He highlights the educational needs of patients and caregivers, as well as the essential role of community and academic collaboration before and after treatment. Dr. Westin also discusses the use of minimal/measurable residual disease (MRD) in treatment planning, future directions of CAR-T, and ongoing clinical trials. Tune in to stay up-to-date on the latest advancements in CAR T-cell therapy! This episode is supported by Allogene Therapeutics, Bristol Myers Squibb, Johnson& Johnson & Legend Biotech, and Kite, a Gilead Company.

Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on January 7, 2025 Jaehyuk (Jae) Choi, MD Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics Northwestern University Feinberg School of Medicine Chicago, IL In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma (CTCL), covering key diagnostic tools, emerging therapies, and the importance of a multidisciplinary team approach. He delves into effective symptom management, including the psychosocial impact of pruritus, and discusses the latest ongoing research. Additionally, Dr. Choi highlights disparities in diagnosis, treatment access, and patient outcomes. Tune in today to gain valuable insights on this complex diagnosis! This episode is supported by Kyowa Kirin, Inc.

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2024 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today! This episode is supported by Autolus Therapeutics.

Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL Recorded on November 21, 2024 Celeste Bello, MD Senior Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!

Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN Recorded on November 14, 2024 Lynn Gooden, BSN, RN, ONN-CG Oncology Navigation and Survivorship Manager Oncology Navigation Community Health Network MD Anderson Cancer Center Indianapolis, IN Cassie Osborne, MSN, RN, OCN, ONN-CG Oncology Nurse Navigator Oncology Navigation-Hematology/Sarcoma/Brain/Skin Community Health Network MD Anderson Cancer Center Indianapolis, IN Join us for this important episode, as Lynn Gooden and Cassie Osborne, nurses from the Community Health Network MD Anderson Cancer Center in Indianapolis, discuss mental health challenges faced by survivors of cancer, including the impact of long-term and late effects. They explore how a multidisciplinary team can address both physical and psychosocial needs, and caregiver involvement in decision-making and support. Resources are also highlighted for healthcare professional education, along with support resources for survivors and caregivers to enhance survivorship. Tune in to today for this insightful discussion! This episode is supported by Genentech, A Member of the Roche Group.

Kerry A. Rogers, MD, The Ohio State University, Columbus, OH Recorded on October 29, 2024 Kerry A. Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, OH Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today!

Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT Recorded on July 2, 2024 Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more! Jennifer R. Rushton, MD Clinical Pathology Associates Medical Director, Pathology and Laboratory Medicine Baptist Health System San Antonio, TX Eric Severson, MD, PhD Executive Director Medical Affairs and Evidence Generation Labcorp Oncology Shelton, CT This episode is supported by Labcorp Oncology.

Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on September 20, 2024 Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society's Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare! Stacie B. Dusetzina, PhD Professor, Health Policy Ingram Professor of Cancer Research Vanderbilt University Medical Center Nashville, TN Bethany Lilly, JDExecutive Director, Public Policy The Leukemia & Lymphoma Society Rye Brook, NY Resources mentioned in this episode: American Cancer Society Centers for Medicare and Medicaid Services Medicare Plan Finder State Health Insurance Assistance Program (SHIP) The Leukemia & Lymphoma Society Triage Cancer

Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA Recorded on June 27, 2024 Alex F. Herrera, MD Associate Professor Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation Associate Medical Director, Briskin Center for Clinical Research & City of Hope Duarte Clinical Trials Office City of Hope Medical Center Duarte, CA In this episode, Dr. Alex Herrera from City of Hope explores the intricacies of Hodgkin lymphoma, from diagnosis and monitoring techniques to treatment goals and options. He discusses emerging therapies, including the significance of clinical trials, strategies for managing side effects, long-term effects of treatment, and resources for healthcare professionals, patients, and families. Tune in to learn more today!

Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA Recorded on September 9, 2024 Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Shira Dinner, from Northwestern University, and Dr. Tom Martin, from University of California San Francisco, about their insights and key takeaways from the conference. Learn more by tuning in here! Shira Dinner, MD Associate Professor Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, IL Tom Martin, MDClinical Professor of Medicine, Division of Hematology/Oncology Director, Clinical Research, Hematologic Malignancies Program Co-Leader, Cancer Immunology and Immunotherapy Associate Director, Myeloma Program University of California San Francisco San Francisco, CA

Krish Patel, MD, Swedish Cancer Institute, Seattle, WA Recorded on June 6, 2024 Krish Patel, MD Director, Lymphoma Program Director, Hematologic Malignancies and Cellular Therapy Swedish Cancer Institute Seattle, WA Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on mantle cell lymphoma today!

Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA Recorded on June 4, 2024 Ximena Jordan-Bruno, MD Assistant Professor, Division of Hematology/Oncology University of Pennsylvania Philadelphia, PA Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition syndromes. Learn about key clinical features, diagnostic approaches, the role of genetic counseling, and future research directions. Tune in today for valuable updates to enhance your understanding and practice!

Susan Hong, MD, Virginia Commonwealth University, Richmond, VA Recorded on May 21, 2024 Susan Hong, MD Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center Associate Professor, School of Medicine Internal Medicine Virginia Commonwealth University Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University's Massey Cancer Center, discusses survivorship care in adults. She explores the intersection of healthcare professional and patient goals in survivorship care, as well as disparities and challenges impacting access and follow-up. Dr. Hong offers strategies to improve adherence to survivorship care and communication between survivors and primary care practitioners. She also shares educational resources for healthcare professionals, patients, and caregivers to support effective survivorship care. Listen to this informative episode today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA Recorded on April 25, 2024 David Dean, DDS, MSD, DABOM, FDS RCSEd Director, Oral Medicine Fred Hutchinson Cancer Center Clinical Associate Professor University of Washington School of Dentistry Seattle, WA Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that arise from treatment, and insights into preventative care. Dr. Dean also addresses special considerations for patients with cancer needing dental care and strategies for healthcare providers to provide optimal support for patients navigating dental challenges. Tune in to learn more today!

Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY Recorded on April 16, 2024 Cesar Rodriguez, MD Associate Professor of Medicine, Tisch Cancer Institute Clinical Director, Multiple Myeloma Center of Excellence Mount Sinai Hospital New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider's role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of language and cultural considerations, along with the importance of caregiver support for older adult survivors. Listen in today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

Karen E. Effinger, MD, MS, Children's Healthcare of Atlanta, Atlanta, GA Recorded on April 4, 2024 Karen E. Effinger, MD, MS Associate Professor of Pediatrics Emory University School of Medicine Co-Director, Survivor Program Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta Atlanta, GA In this episode, Dr. Karen Effinger from Children's Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX Recorded on March 28, 2024 Hagop M. Kantarjian, M.D. Professor and Chairman, Department of Leukemia Samsung Distinguished University Chair in Cancer Medicine MD Anderson Cancer Center, University of Texas Houston, TX Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO Recorded on March 12, 2024 Michael Tees, MD, MPH Director, Lymphoma Program Lymphoma Executive Committee Member, Sarah Cannon Research Institute Associate Member, Colorado Blood Cancer Institute Denver, CO Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more! This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.

Alfred Lee, MD, PhD, Yale University, New Haven, CT Recorded on February 22, 2024 Alfred Lee, MD, PhD Professor of Medicine, Yale School of Medicine Program Director, Hematology and Medical Oncology Fellowship Chief, Division of Classical Hematology, Yale Cancer Center Yale University New Haven, CT Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today!

Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL Recorded on December 7, 2023 Meghna Ailawadhi, M.B.B.S., M.D. Cancer Survivorship Consultant, Assistant Professor of Medicine Department of Hematology/Oncology Mayo Clinic Jacksonville, FL In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care, including strategies to support adherence. She also provides an overview of disparities and challenges in survivorship care, as well as education and support resources for healthcare professionals and survivors. Learn more by listening today! This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2023 Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical trials in leukemia, lymphoma, myeloma, MDS, and MPNs. Tune in to this informative update today!

Jeffery Auletta, MD, National Marrow Donor Program® (NMDP)/Be the Match® Recorded on November 30, 2023 Join us as Dr. Jeffery Auletta from the National Marrow Donor Program® (NMDP)/Be the Match® reflects on the history, advances, and future of transplantation to treat blood cancers. Dr. Auletta also shares insights on disparities and barriers to receiving a transplant, expanding access, and how healthcare professionals can support patients through transplantation. Tune in to this engaging episode today!

Jacqueline Barrientos, MD, MS, Laura Ortiz-Ravick, MA, Kristina Lopez, LCSW Recorded on November 3, 2023 Join us for this special episode, recorded live from the Florida Society of Clinical Oncology Annual Disparities in Cancer Care Summit. Guest host, Kristina Lopez, LCSW and Information Specialist at The Leukemia & Lymphoma Society, speaks with Dr. Jacqueline Barrientos from Mount Sinai Medical Center, and Laura Ortiz-Ravick, Director of Outreach and Health Promotion at The Leukemia & Lymphoma Society about barriers and disparities within the Hispanic and Latinx communities when navigating the cancer journey. Learn more by tuning in here!

Survivorship Care of Older Adults: Addressing the Unique Needs Frank Penedo, Ph.D, University of Miami, Miami, FL Recorded on August 10, 2023 Tune in as we're joined by Dr. Frank Penedo from the University of Miami for an important discussion on considerations in survivorship care of older adults. Dr. Penedo outlines long-term and late effects of treatment, including psychosocial implications, and the impact of culture and language on survivorship. He also shares strategies for follow-up care coordination, as well as communicating with survivors and their families. Be part of the conversation today! This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.

John Salsman, Ph.D, Wake Forest University School of Medicine, Winston-Salem, NC Recorded on June 22, 2023 In this episode, Dr. John Salsman from Wake Forest University School of Medicine joins special staff correspondent, Elissa Baldwin, to discuss quality of life in the cancer experience of adolescents and young adults (AYAs), including unique issues that AYAs face. Dr. Salsman offers approaches to questions healthcare providers can ask when communicating with AYAs and clinical resources for physicians and survivors. Tune in today!

Tung Wynn, MD, University of Florida, Gainesville, FL and Braulio Hernandez Recorded on June 10, 2023 Join Dr. Tung Wynn from the University of Florida, and Braulio Hernandez, a childhood cancer advocate and AYA survivor of Hodgkin Lymphoma, as they discuss the unique experiences of adolescents and young adults from active treatment to survivorship. Dr. Wynn and Braulio reflect on the physical and psychosocial long-term and late effects of treatment, strategies to support survivors and their families, survivorship guidelines, follow-up care coordination, and resources for clinical staff and for survivors. Listen to this engaging conversation today! This podcast episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc., Pharmacyclics LLC, An AbbVie Company & Janssen Biotech, Inc.

Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on April 13, 2023 In this important conversation, Dr. Chasity Burrows Walters from Memorial Sloan Kettering Cancer Center discusses the barriers that persons within the LGBTQI+ community experience in accessing healthcare and the impact of discrimination on health outcomes. Dr. Burrows Walters offers guidance to help healthcare providers foster a respectful and sensitive environment for patients and their caregivers, including use of pronouns, gender-inclusive language, cancer screening guidelines, and resources for clinical staff and for patients. Learn more by tuning in today!

Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI Recorded on January 24, 2023 In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discuss chronic myeloid leukemia (CML) including the development of tyrosine kinase inhibitors (TKIs), challenges with adherence to treatment, side effect management, and long-term and late effects, including cardiac toxicities. Dr. Atallah describes the work of the H. Jean Khoury Cure CML Consortium, shares his insights in to transitioning patients off TKIs, experience with his patients living with measurable residual disease, and excitement about the future of CML therapy. Learn more by tuning in today!

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2022 In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide an update on the information presented at the 64th American Society of Hematology (ASH) Annual Meeting, including leukemia, lymphoma, myeloma, MDS, and MPNs. Dr. Greenberger discusses updates in blood cancer therapies, including CAR T-cell therapy, bi-specific antibodies, and vaccine therapy, reviews the latest data on COVID-19, and addresses challenges that exist in diversity and equity in the healthcare system, including ways to overcome these barriers. Tune in today!

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA Recorded on December 6, 2022 Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic factors? Dr. Shayna Sarosiek, from the Dana-Farber Cancer Institute, joins us to provide a deep dive into WM, including testing, monitoring, treatment updates, clinical trials, and so much more. Tune in today! This activity is developed through a collaboration with the International Waldenström's Macroglobulinemia Foundation.

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX Recorded on December 16, 2022 Chimeric antigen receptor (CAR) T-cell therapy has generated impressive results in hematologic malignancies, with many drugs still in clinical trials. In this episode, Dr. Sattva S. Neelapu from MD Anderson Cancer Center, joins us to discuss updates on CAR T-cell therapy from the 2022 American Society of Hematology (ASH) Annual Meeting. Dr. Neelapu also provides a high-level overview of how CAR T-cell therapy works, including the manufacturing process, and discusses the risk of recurrence following therapy, risk for patients in the era of COVID-19, secondary cancers, associated costs, roadblocks to therapy, and why early referral matters. Tune in to this informative podcast episode to learn more! This podcast episode is supported by Allogene Therapeutics, Bristol Myers Squibb, CRISPR Therapeutics, Janssen Oncology & Legend Biotech, Kite, A Gilead Company and Novartis Oncology.

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC Recorded on October 20, 2022 In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discusses the importance of a relationship between the provider and the patient when it comes to shared decision making (SDM), including the unique conversations of SDM with young adults and with healthcare providers who are patients. Dr. Friedman also shares challenges with seeking a second opinion, relying on information found on the internet, and additional resources. Tune in today to learn more! This podcast episode is supported by AbbVie Inc. and Genentech, Inc.

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 7, 2022 Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect on breakthroughs in acute myeloid leukemia, including updates in treatment, long-term and late effects of therapy, and side effect management. Tune in to this episode as Dr. Stein presents an overview of data presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) as well as updates from The Leukemia & Lymphoma Society's BEAT AML Master Trial.

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on September 30, 2022 Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Saad Usmani, from Memorial Sloan Kettering Cancer Center, about his insights into the progress in immunotherapies in blood cancers shared at the conference. Not able to attend SOHO? Learn more about what was shared at the conference by tuning in here! 

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on September 6, 2022 Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju provides an overview of BPDCN, including major updates in the treatment of the disease since our last episode on this topic in 2019. What is BPDCN? How is it treated? Is it curable? What resources are available for patients living with this rare disease? Join the conversation and learn more today!   This podcast episode is supported by Stemline Therapeutics, Inc.

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA Recorded on July 19, 2022 Mastocytosis is a rare and complex disease. In this special episode, Dr. Jason Gotlib from the Stanford University School of Medicine in Palo Alto, CA, discusses an overview of the disease, including its subtypes, clinical presentations, and treatment related toxicities. Dr. Gotlib addresses the importance of second opinions, collaborating with multidisciplinary specialists to treat patients, unmet needs and exciting new and emerging treatments. Learn more about the future of mastocytosis by listening to this episode today!    This podcast episode is supported by Blueprint Medicines Corporation.

Rafael Fonseca, MD, Getz Family Professor of Cancer, Phoenix, AZ Recorded on June 30, 2022 In this episode, Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, joins Dr. Ken Miller to breakdown the complex and complicated nature of genomics and molecular profiling. He discusses the role of molecular profiling in treating blood cancers, explains how we integrate genomics into the standard of care for people living with cancer, the potential of false negatives, provides examples of clinical applications, financial implications, and resources for patients. Tune in to the conversation today! This podcast episode is supported by Blueprint Medicines Corporation.

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC Recorded on June 9, 2022 Children diagnosed with cancer are a heterogenous population experiencing difference cancer diagnoses and therapies. Each journey presents its own physical, emotional, and psychosocial challenges that healthcare providers need to be attentive to. In this episode, Dr. Kevin Oeffinger, from Duke University in Durham, North Carolina, joins us to discuss the history of pediatric survivorship, physical, long-term, and late effects of treatment, including fertility considerations, strategies to support the survivor through psychosocial and cognitive effects, following a survivorship care plan, symptom monitoring, follow-up care, and so much more. Tune in to this important conversation today! This podcast episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company and Janssen Biotech, Inc.

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on May 20, 2022 Through the LLS Children's Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provides free education, support services, financial assistance, advocacy efforts, and has increased its research investments in childhood blood cancer. As part of this initiative, LLS PedAL, a first-of-its-kind global master clinical trial for pediatric acute leukemia patients, will fundamentally change how children are treated. In this episode, Dr. Gwen Nichols, EVP and Chief Medical Officer joins us to discuss PedAL, including sharing reflections on lack of pediatric ALL and AML therapies that led to the development of this master clinical trial. Dr. Nichols discusses challenges in creating pediatric therapies, the importance of data collection and creating a standard of care, and the ultimate impact PedAL will have on all clinical trials moving forward. Tune in today!

Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ Recorded on May 3, 2022 The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to appropriate referral to a hematologist-oncologist, from coordination of care to goals of therapy. In this episode, we are joined by Dr. Zalman Suldan, from Hackensack Medical Center in New Jersey, who shares his unique insights as both a primary care physician and nephrologist. Tune in today! This podcast episode is supported by Janssen Oncology, Pharmaceutical Companies of Johnson & Johnson.

Rayne H. Rouce, MD, BS, Texas Children's Cancer Center for Cell and Gene Therapy, Houston, TX Recorded on April 8, 2022 As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxicities reduced. In this episode, Dr. Rayne Rouce, from the Texas Children's Cancer Center for Cell and Gene Therapy at Baylor College in Houston, joins us to discuss hot topics in CAR T-cell therapy, including how CAR-T has evolved over the past few years, understanding why some patients do better than others, access to treatment and overcoming logistics, shared care models with the referring physician, CAR-T in pediatric patients, communicating with patients, and so much more! This podcast episode is supported by Bristol Myers Squibb, CRISPR Therapeutics, Kite, a Gilead Company, Janssen Oncology & Legend Biotech, and Novartis Pharmaceuticals Corporation.

Francine Foss, MD and John A. Zic, MD, MMHC Recorded on March 28, 2022 This informative episode covers everything you need to know about cutaneous T-cell lymphoma, from its biology, subclassifications, targeted therapy, goals of treatment, novel toxicities, and so much more! Join Dr. Ken Miller as he delves into cutaneous T-cell lymphoma with two special guests; Dr. Francine Foss from Yale University School of Medicine and Dr. John Zic from Vanderbilt University Medical Center. Learn more about cutaneous T-cell lymphoma from a 60,000 foot view, disparities in the delivery of care, and exciting new research presented at the United States Cutaneous Lymphoma Consortium Annual Meeting. Tune in today!

Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX Recorded on February 18, 2022 In this month's episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to discuss myelofibrosis. What is myelofibrosis? What is our understanding of the disease? What are the deciding factors for cells to branch off into myelofibrosis and not other myeloproliferative neoplasms? Tune in as we explore myelofibrosis, including discussion on diagnosing and staging, goals and considerations for therapy, the impact of COVID-19 on treatment, and new and emerging drugs in development. This podcast episode is supported by AbbVie Inc.

Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY Recorded on February 1, 2022 Shared decision making between patients and their healthcare team is an important component to treatment, regardless of the diagnosis. For chronic leukemias, patient worries may be intensified when doctors suggest forgoing active treatment for a watch-and-wait approach. In this episode, Dr. Jacqueline Barrientos, from the Northwell Health Cancer Institute in Lake Success, New York, highlights the importance of shared decision making with her patients. Dr. Barrientos discusses challenges that arise, shared decision making across the multidisciplinary team, navigating second opinions, long-term and late effects, and maintaining open lines of communication. Listen in on this important conversation today! This podcast episode is supported by AbbVie Inc. and Genentech, Inc.